IPO News | Acrobiosystems (301080.SZ) Submits Application to Hong Kong Stock Exchange

Stock News

Jan 26

According to a disclosure by the Hong Kong Stock Exchange on January 26, Beijing Acrobiosystems Biotech Co., Ltd. (Acrobiosystems, 301080.SZ) has submitted a listing application for the main board, with China Merchants Securities International acting as its sole sponsor. The prospectus reveals that Acrobiosystems is a global provider of life science tools and technical services, dedicated to empowering biopharmaceutical companies across the entire value chain from R&D and production to clinical application. According to data from Frost & Sullivan, in the global recombinant protein market, the company ranked first among all domestic Chinese suppliers and third among all global suppliers by 2024 revenue.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1133595595"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1133595595\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1133595595?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-26 20:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1133595595","market":"fut","top_or_hot":-1,"title":"IPO News | Acrobiosystems (301080.SZ) Submits Application to Hong Kong Stock Exchange","media":"Stock News","content":"<p>According to a disclosure by the Hong Kong Stock Exchange on January 26, Beijing Acrobiosystems Biotech Co., Ltd. (Acrobiosystems, 301080.SZ) has submitted a listing application for the main board, with China Merchants Securities International acting as its sole sponsor. The prospectus reveals that Acrobiosystems is a global provider of life science tools and technical services, dedicated to empowering biopharmaceutical companies across the entire value chain from R&D and production to clinical application. According to data from Frost & Sullivan, in the global recombinant protein market, the company ranked first among all domestic Chinese suppliers and third among all global suppliers by 2024 revenue.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IPO News | Acrobiosystems (301080.SZ) Submits Application to Hong Kong Stock Exchange</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIPO News | Acrobiosystems (301080.SZ) Submits Application to Hong Kong Stock Exchange\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-01-26 20:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>According to a disclosure by the Hong Kong Stock Exchange on January 26, Beijing Acrobiosystems Biotech Co., Ltd. (Acrobiosystems, 301080.SZ) has submitted a listing application for the main board, with China Merchants Securities International acting as its sole sponsor. The prospectus reveals that Acrobiosystems is a global provider of life science tools and technical services, dedicated to empowering biopharmaceutical companies across the entire value chain from R&D and production to clinical application. According to data from Frost & Sullivan, in the global recombinant protein market, the company ranked first among all domestic Chinese suppliers and third among all global suppliers by 2024 revenue.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0216","symbol_name":"研究试验","start_time":0,"source_url":"","article_id":"1133595595","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1133595595","pubTimestamp":1769430738,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"According to a disclosure by the Hong Kong Stock Exchange on January 26, Beijing Acrobiosystems Biotech Co., Ltd. (Acrobiosystems, 301080.SZ) has submitted a listing application for the main board,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"91378":"北京百普赛斯生物科技股份有限公司（临时代码）","301080":"百普赛斯","BK0216":"研究试验"},"translate_title":"IPO快讯|Acrobiosystems(301080.SZ)向港交所递交申请","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"91378":0.95,"301080":1,"HEXmain":1},"content_text":"According to a disclosure by the Hong Kong Stock Exchange on January 26, Beijing Acrobiosystems Biotech Co., Ltd. (Acrobiosystems, 301080.SZ) has submitted a listing application for the main board, with China Merchants Securities International acting as its sole sponsor. The prospectus reveals that Acrobiosystems is a global provider of life science tools and technical services, dedicated to empowering biopharmaceutical companies across the entire value chain from R&D and production to clinical application. According to data from Frost & Sullivan, in the global recombinant protein market, the company ranked first among all domestic Chinese suppliers and third among all global suppliers by 2024 revenue.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}